Strong TAA-specific CD8+ T cell response inhibited HCC recurrence. For patients with HCC following local therapy, induction of TAA-specific cytotoxic T lymphocytes should be considered with immunotherapy, such as peptide vaccine. The gene discussed is CD8A; the disease is hepatocellular carcinoma.